Lv01
0 积分 2025-09-22 加入
A randomized, double-blind, phase 3, non-inferiority trial of pradefovir mesylate versus tenofovir disoproxil fumarate in chinese patients with chronic hepatitis B
2小时前
已完结
Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection
2小时前
已完结
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
2小时前
已完结
A prospective post-marketing observational study of abemaciclib in patients with HR+, HER2− breast cancer in China
3个月前
已完结
Cost-effectiveness of tenofovir alafenamide fumarate for treatment of chronic hepatitis B: Evidence from a tertiary hospital in Vietnam
5个月前
已完结
Cost‐Effectiveness of Antiviral Therapy in Patients With High Viremic Indeterminate Phase Chronic Hepatitis B
6个月前
已完结
A Real-World Pharmacological Assessment of Tenofovir Amibufenamide and Tenofovir Alafenamide in 48-Week Chronic Hepatitis B Treatment: Efficacy, Safety, and Cost-Effectiveness
6个月前
已完结
Efficacy and Safety of Vaccines to Prevent Respiratory Syncytial Virus Infection in Infants and Older Adults: A Systematic Review and Meta-analysis
6个月前
已完结
Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis
6个月前
已完结
A Real-World Pharmacological Assessment of Tenofovir Amibufenamide and Tenofovir Alafenamide in 48-Week Chronic Hepatitis B Treatment: Efficacy, Safety, and Cost-Effectiveness
7个月前
已完结
皖公网安备34019202002308
